Skip to Content

Investors

Company Profile

Altimmune is a clinical stage immunotherapeutics biotechnology company located in Montgomery County, MD with an additional operating site in London, UK. By leveraging the complementary attributes of its two innovative vaccine delivery platforms, RespirVec and Densigen, Altimmune is able to design and develop immunotherapeutic products tailored to address a wide range of disease indications including acute respiratory infections, chronic viral infections and cancer, with the potential for fundamental advantages over competing products.

Documents and Files
Session link: 2554. Safety and Immunogenicity of NasoVAX, a Novel Intranasal Influenza Vaccine
2018 Letter to Shareholders
2018 Proxy Statement
H.C. Wainwright Global Life Sciences Conference Presentation
Corporate Presentation
2017 Annual Report on Form 10-K
B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium (CHIPS) Presentation
2017 IRS Form 8937
Biotech Showcase Presentation
Altimmune Expands in Gaithersburg
Source
WDVM

Company Profile

Altimmune is a clinical stage immunotherapeutics biotechnology company located in Montgomery County, MD with an additional operating site in London, UK. By leveraging the complementary attributes of its two innovative vaccine delivery platforms, RespirVec™ and Densigen™, Altimmune is able to design and develop immunotherapeutic products tailored to address a wide range of disease indications including acute respiratory infections, chronic viral infections and cancer, with the potential for fundamental advantages over competing products.

 

Investor Contact

Ashley Robinson
LifeSci Advisors, LLC
Email: arr@lifesciadvisors.com

View all

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Learn more